Zoledronic acid, also known as zoledronate and sold under the brand name Zometa among others, by Novartis among others, is a medication used to treat a number of bone diseases. From Wikipedia
Researchers at EPFL and Flowbone have developed a nanoparticle-based hydrogel that could enhance osteoporosis treatment by significantly boosting localized bone density within weeks.